Involvement of oxidative stress in the profibrotic action of aldosterone - Interaction with the renin-angiotensin system

被引:137
作者
Iglarz, M [1 ]
Touyz, RM [1 ]
Viel, EC [1 ]
Amiri, F [1 ]
Schiffrin, EL [1 ]
机构
[1] Univ Montreal, Clin Res Inst Montreal, CHIR Multidisciplinary Res Grp Hypertens, Montreal, PQ H2W 1R7, Canada
基金
加拿大健康研究院;
关键词
mineralocorticoids; AT(1) angiotensin receptors; collagen; kidney; resistance arteries; hypertrophy;
D O I
10.1016/j.amjhyper.2004.04.005
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: The aim of this study was to investigate the involvement of angiotensin 11 and oxidative stress on cardiovascular damage induced by chronic subcutaneous aldosterone infusion in the absence of salt loading. Methods: Sprague-Dawley rats were infused with d-aldosterone (0.75 mug/h subcutaneously) for 6 weeks. Blood pressure was measured with the tail-cuff method. Small arteries were investigated on a pressurized myograph. Cardiovascular and renal collagen was evaluated by Sirius red staining. Systemic oxidant excess was measured with plasma 8-isoprostane by ELISA and by measurement of thiobarbituric acid-reactive substances. Vascular reactive oxygen species were studied using hydroethidine and NADPH-generated superoxide anion measured by lucigenin chemiluminescence. Results: After 6 weeks of treatment, systolic blood pressure was significantly increased in aldosterone-infused rats (170 +/- 8 v 123 +/- 2 mm Hg in controls, P < .05). Progression of hypertension was partially prevented by co-administration of losartan (AT(1) receptor blocker) or tempol (superoxide dismutase mimetic): 140 +/- 4 and 149 +/- 6 mm Hg, respectively, P < .05 versus the aldosterone group. Aldosterone induced renal but not cardiac hypertrophy, which was not prevented by losartan or by tempol. Moreover, losartan and tempol failed to prevent vascular hypertrophy of resistance mesenteric vessels. However, losartan (0.77% +/- 0.05%) and tempol (0.65% +/- 0.10%) prevented cardiac fibrosis in the midmyocardium in the aldosterone group (1.03% +/- 0.12% v 0.68% +/- 0.07% positive staining per area in control, P < .05). In the kidney, collagen accumulation of aldosterone-infused rats was also significantly decreased by losartan (-77%) and tempol (-60%). Similar effects were obtained on aortic fibrosis. Aldosterone increased serum 8-isoprostane levels. This increase was blunted by losartan and tempol. Losartan and tempol totally prevented vascular, cardiac, and renal increase of NADPH-induced superoxide production stimulated by aldosterone. Conclusions: Our data suggest that the profibrotic but not the hypertrophic action of aldosterone are mediated at least in part by reactive oxygen species generation and involve an interaction with the renin-angiotensin system. (C) 2004 American Journal of Hypertension, Ltd.
引用
收藏
页码:597 / 603
页数:7
相关论文
共 23 条
[1]   Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats:: Role of ETA receptors [J].
Ammarguellat, FZ ;
Gannon, PO ;
Amiri, F ;
Schiffrin, EL .
HYPERTENSION, 2002, 39 (02) :679-684
[2]   Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice [J].
Bendall, JK ;
Cave, AC ;
Heymes, C ;
Gall, N ;
Shah, AM .
CIRCULATION, 2002, 105 (03) :293-296
[3]   Mineralocorticoid receptor affects AP-1 and nuclear factor-κB activation in angiotensin II-Induced cardiac injury [J].
Fiebeler, A ;
Schmidt, F ;
Müller, DN ;
Park, JK ;
Dechend, R ;
Bieringer, M ;
Shagdarsuren, E ;
Breu, V ;
Haller, H ;
Luft, FC .
HYPERTENSION, 2001, 37 (02) :787-793
[4]   Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes [J].
Harada, E ;
Yoshimura, M ;
Yasue, H ;
Nakagawa, O ;
Nakagawa, M ;
Harada, M ;
Mizuno, Y ;
Nakayama, M ;
Shimasaki, Y ;
Ito, T ;
Nakamura, S ;
Kuwahara, K ;
Saito, Y ;
Nakao, K ;
Ogawa, H .
CIRCULATION, 2001, 104 (02) :137-139
[5]   ALDOSTERONE REGULATION OF GENE-TRANSCRIPTION LEADING TO CONTROL OF ION-TRANSPORT [J].
HORISBERGER, JD ;
ROSSIER, BC .
HYPERTENSION, 1992, 19 (03) :221-227
[6]   Effect of peroxisome proliferator-activated receptor-α and -γ activators on vascular remodeling in endothelin-dependent hypertension [J].
Iglarz, M ;
Touyz, RM ;
Amiri, F ;
Lavoie, MF ;
Diep, QN ;
Schiffrin, EL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (01) :45-51
[7]   Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats [J].
Lacolley, P ;
Labat, C ;
Pujol, A ;
Delcayre, C ;
Benetos, A ;
Safar, M .
CIRCULATION, 2002, 106 (22) :2848-2853
[8]   Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: Role of endothelin-1 [J].
Park, JB ;
Schiffrin, EL .
AMERICAN JOURNAL OF HYPERTENSION, 2002, 15 (02) :164-169
[9]   The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].
Pitt, B ;
Zannad, F ;
Remme, WJ ;
Cody, R ;
Castaigne, A ;
Perez, A ;
Palensky, J ;
Wittes, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717
[10]   Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling [J].
Pu, Q ;
Neves, MF ;
Virdis, A ;
Touyz, RM ;
Schiffrin, EL .
HYPERTENSION, 2003, 42 (01) :49-55